MOTS
Motus GI Holdings Inc
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
motus gi holdings, inc. (nasdaq: mots) is a medical technology company based in the u.s., with subsidiaries in the u.s. and israel, dedicated to improving endoscopy outcomes, lowering costs and enhancing patient experiences. the company is focused on the development and commercialization of the pure-vu® system, designed to improve the colonoscopy experience and assist in the early detection and prevention of colorectal cancer and other diseases of the rectum and colon. the pure-vu® system is a 510(k) u.s. food and drug administration cleared medical device indicated to help facilitate the cleaning of a poorly prepared colon during the colonoscopy procedure. the device integrates with standard colonoscopes to enable cleaning during the procedure while preserving standard procedural workflow and techniques. the pure-vu® system has received ce mark approval in europe.
Market Cap: 441 Thousand
Primary Exchange: NASDAQ
Website: https://www.motusgi.com/
Shares Outstanding: 690 Thousand
Float: 0
Dividend: 0.0 (0.0%)
Beta: 0.22214369639831852
Sector: Manufacturing
Industry: Surgical and Medical Instrument Manufacturing
Ethical Flags
Longest drawdown: 3114 trading days
From: 2018-07-06 To: 2024-03-07
Lowest Point:
MT, ZYNE among premarket gainers
via: SeekingAlpha at 2019-06-11 05:21:22:000
Jaguar Health (NASDAQ: JAGX ) +56% as its subsidiary receives preclinical services funded by the National Institute of Allergy and Infectious Diseases. More news on: Jaguar Health, Inc., NovaBay Pharmaceuticals, Inc., Motus GI Holdings, Inc., Stocks on the move, Read more … ... read more...
MT, ZYNE among premarket gainers
via: SeekingAlpha at 2019-06-11 05:21:22:000
Jaguar Health (NASDAQ: JAGX ) +56% as its subsidiary receives preclinical services funded by the National Institute of Allergy and Infectious Diseases. More news on: Jaguar Health, Inc., NovaBay Pharmaceuticals, Inc., Motus GI Holdings, Inc., Stocks on the move, Read more … ... read more...
MT, ZYNE among premarket gainers
via: SeekingAlpha at 2019-06-11 05:21:22:000
Jaguar Health (NASDAQ: JAGX ) +56% as its subsidiary receives preclinical services funded by the National Institute of Allergy and Infectious Diseases. More news on: Jaguar Health, Inc., NovaBay Pharmaceuticals, Inc., Motus GI Holdings, Inc., Stocks on the move, Read more … ... read more...
Motus GI Receives FDA Clearance to Market Pure-Vu® GEN2
via: Business Wire at 2019-06-11 03:30:00:000
FDA clearance marks key regulatory milestone and advances commercial strategy for launch in U.S. hospital market in 2019 Motus GI Holdings, Inc. , (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company dedicated to improving clinical outcomes and… read more...
Motus GI Receives FDA Clearance to Market Pure-Vu® GEN2
via: Business Wire at 2019-06-11 03:30:00:000
FDA clearance marks key regulatory milestone and advances commercial strategy for launch in U.S. hospital market in 2019 Motus GI Holdings, Inc. , (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company dedicated to improving clinical outcomes and… read more...
Motus GI Receives FDA Clearance to Market Pure-Vu® GEN2
via: Business Wire at 2019-06-11 03:30:00:000
FDA clearance marks key regulatory milestone and advances commercial strategy for launch in U.S. hospital market in 2019 Motus GI Holdings, Inc. , (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company dedicated to improving clinical outcomes and… read more...
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|